Table 2.
Laboratory Findings at Study Entry
| COVIDstable
(n = 20) |
COVIDICU
(n = 20) |
CAPICU
(n = 15) |
||||
|---|---|---|---|---|---|---|
| Mean (SD) | Median | Mean (SD) | Median | Mean (SD) | Median | |
| White cell count (4.0–11.0) | 8.29 (2.27) | 7.99 | 13.12 (5.36) | 12.22 | 16.31 (5.77) | 16.00 |
| Neutrophils (2.0–7.5) | 7.85 (3.18) | 6.95 | 11.17 (5.17) | 10.29 | 14.11 (5.12) | 12.41 |
| Lymphocytes (1.0–4.0) | 1.55 (0.66) | 1.46 | 1.09 (0.34) | 1.03 | 1.88 (0.89) | 1.80 |
| Monocytes (0.2–1.0) | 0.65 (0.25) | 0.58 | 0.41 (0.25) | 0.38 | 0.84 (0.43) | (0.66) |
| Eosinophils (0.04–0.4) | 0.04 (0.02) | 0.02 | 0.01 (0.01) | 0.000 | 0.1 (0.07) | 0.07 |
| Platelets (140–400) | 266 (56.4) | 253 | 228 (54.2) | 236 | 226 (52.2) | 230 |
| Hb (13.0–17.5 g/dl) | 13.7 (1.08) | 13.1 | 12.9 (1.44) | 12.8 | 13.0 (1.39) | 12.9 |
| C-reactive protein (0–5 mg/L) | 62.1 (61.7) | 47 | 232 (104.5) | 192 | 253 (101.4) | 272 |
| Aspartate aminotransferase (0–40 U/L) | 51 (24.0) | 38 | 63 (21.4) | 66 | 59 (23.2) | 53 |
| Alanine aminotransferase (0–41 IU/L) | 59 (40.3) | 43 | 47 (16.1) | 49 | 49 (15.8) | 46 |
| γ-Glutamyltransferase (0–59 IU/L) | 74 (57.6) | 57 | 94 (52.8) | 90 | 62 (38.9) | 60 |
| Bilirubin (0–21 μmol/L) | 8 (2.8) | 9 | 10 (4.3) | 9 | 8 (3.1) | 8 |
| Albumin (35–52 g/L) | 37 (4.82) | 37 | 33 (5.76) | 34 | 34 (4.32) | 34 |
| Fibrinogen (1.90–3.50 g/L) | 3.98 (0.72) | 4.00 | 5.14 (1.13) | 4.70 | 4.22 (0.36) | 4.10 |
| Ferritin* (30–400 ng/ml) | 1,710 (863) | 1,473 | 1,812 (1,276) | 1,599 | 773 (421) | 796 |
| Lactate (0.5–1.0 mmol/L) | 0.9 (0.3) | 0.9 | 2.9 (1.3) | 2.9 | 2.8 (1.2) | 2.8 |
| Lactate dehydrogenase† (135–225 U/L) | 304 (105.8) | 267 | 806 (102.2) | 787 | 332 (98.4) | 320 |
| Alpha-1 antitrypsin (0.90–1.80 g/L) | 2.10 (0.51) | 2.16 | 2.89 (0.49) | 2.85 | 2.85 (0.39) | 2.85 |
Definition of abbreviations: CAPICU = patients with severe community-acquired pneumonia requiring ICU support; COVID-19 = coronavirus disease; COVIDICU = patients with COVID-19 requiring ICU admission; COVIDstable = hospitalized but stable patients with COVID-19.
Reference ranges for each blood measurement are included in parentheses.
*
Data available for 39 patients with COVID-19 and 13 patients with community-acquired pneumonia.
†
Data available for 37 patients with COVID-19 and 13 patients with community-acquired pneumonia. All cell counts are ×109/L.